|
Structure‐guided envelope trimer design in HIV‐1 vaccine development: a narrative review
|
journal
|
November 2021 |
|
Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
|
journal
|
November 2021 |
|
UCSF ChimeraX : Structure visualization for researchers, educators, and developers
|
journal
|
October 2020 |
|
Measuring HIV Neutralization in a Luciferase Reporter Gene Assay
|
book
|
January 2009 |
|
Designed protein multimerization and polymerization for functionalization of proteins
|
journal
|
January 2022 |
|
Brolucizumab: First Approval
|
journal
|
November 2019 |
|
Tebentafusp: First Approval
|
journal
|
April 2022 |
|
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
|
journal
|
November 1986 |
|
Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus
|
journal
|
April 1988 |
|
[20] Processing of X-ray diffraction data collected in oscillation mode
|
book
|
January 1997 |
|
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|
journal
|
August 2020 |
|
Maturation of HIV envelope glycoprotein precursors by cellular endoproteases
|
journal
|
November 2000 |
|
Co-receptors for HIV-1 entry
|
journal
|
August 1997 |
|
Structure of bacteriophage T4 fibritin: a segmented coiled coil and the role of the C-terminal domain
|
journal
|
June 1997 |
|
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
|
journal
|
October 2021 |
|
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases
|
journal
|
September 2021 |
|
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes
|
journal
|
December 2015 |
|
Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice
|
journal
|
September 2016 |
|
Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines
|
journal
|
March 2018 |
|
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface
|
journal
|
May 2019 |
|
Cleavage-Independent HIV-1 Env Trimers Engineered as Soluble Native Spike Mimetics for Vaccine Design
|
journal
|
April 2015 |
|
Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers
|
journal
|
June 2015 |
|
Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies
|
journal
|
August 2016 |
|
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization
|
journal
|
August 2017 |
|
Rational Design of DNA-Expressed Stabilized Native-Like HIV-1 Envelope Trimers
|
journal
|
September 2018 |
|
Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines
|
journal
|
March 2020 |
|
Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike
|
journal
|
April 2021 |
|
Virus vaccines: proteins prefer prolines
|
journal
|
March 2021 |
|
Recent advances in mRNA vaccine technology
|
journal
|
August 2020 |
|
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial
|
journal
|
February 2022 |
|
Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers
|
journal
|
May 2014 |
|
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
|
journal
|
September 2016 |
|
A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure
|
journal
|
April 2017 |
|
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
|
journal
|
May 2018 |
|
Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization
|
journal
|
August 2018 |
|
Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized mice
|
journal
|
November 2022 |
|
Very Fast Folding and Association of a Trimerization Domain from Bacteriophage T4 Fibritin
|
journal
|
April 2004 |
|
Protein and Glycan Mimicry in HIV Vaccine Design
|
journal
|
May 2019 |
|
Automated molecular microscopy: The new Leginon system
|
journal
|
July 2005 |
|
Appion: An integrated, database-driven pipeline to facilitate EM image processing
|
journal
|
April 2009 |
|
RELION: Implementation of a Bayesian approach to cryo-EM structure determination
|
journal
|
December 2012 |
|
Effect of epitope variant co-delivery on the depth of CD8 T cell responses induced by HIV-1 conserved mosaic vaccines
|
journal
|
June 2021 |
|
Engineering Cas9 for human genome editing
|
journal
|
August 2021 |
|
HIV vaccinology: 2021 update
|
journal
|
January 2021 |
|
The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect
|
journal
|
July 2013 |
|
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform
|
journal
|
May 2021 |
|
Effect of trimerization motifs on quaternary structure, antigenicity, and immunogenicity of a noncleavable HIV-1 gp140 envelope glycoprotein
|
journal
|
December 2009 |
|
Enhanced human receptor binding by H5 haemagglutinins
|
journal
|
May 2014 |
|
Glycosylation Analysis of Engineered H3N2 Influenza A Virus Hemagglutinins with Sequentially Added Historically Relevant Glycosylation Sites
|
journal
|
August 2015 |
|
Crystal structure of an isoleucine-zipper trimer
|
journal
|
September 1994 |
|
Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection
|
journal
|
April 2016 |
|
Antibody neutralization and escape by HIV-1
|
journal
|
March 2003 |
|
Broad neutralization coverage of HIV by multiple highly potent antibodies
|
journal
|
September 2011 |
|
Cross-neutralization of influenza A viruses mediated by a single antibody loop
|
journal
|
September 2012 |
|
A stamp on the envelope
|
journal
|
October 2014 |
|
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
|
journal
|
April 2016 |
|
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
|
journal
|
May 2012 |
|
Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability
|
journal
|
June 2016 |
|
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability
|
journal
|
November 2016 |
|
mRNA vaccines — a new era in vaccinology
|
journal
|
January 2018 |
|
Self-amplifying RNA vaccines for infectious diseases
|
journal
|
October 2020 |
|
Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimer
|
journal
|
May 2018 |
|
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence
|
journal
|
May 2019 |
|
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
|
journal
|
September 2019 |
|
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
|
journal
|
February 2021 |
|
High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers
|
journal
|
February 2022 |
|
Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidates
|
journal
|
November 2022 |
|
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques
|
journal
|
May 2019 |
|
Quadrivalent influenza nanoparticle vaccines induce broad protection
|
journal
|
March 2021 |
|
Highly accurate protein structure prediction with AlphaFold
|
journal
|
July 2021 |
|
Broadly neutralizing antibodies target a haemagglutinin anchor epitope
|
journal
|
December 2021 |
|
Recent progress in broadly neutralizing antibodies to HIV
|
journal
|
October 2018 |
|
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
|
journal
|
June 2018 |
|
A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
|
journal
|
December 2021 |
|
IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells
|
journal
|
September 2018 |
|
Engineered viral vaccine constructs with dual specificity: Avian influenza and Newcastle disease
|
journal
|
May 2006 |
|
HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120
|
journal
|
July 2012 |
|
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
|
journal
|
October 2012 |
|
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9
|
journal
|
February 2013 |
|
Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation
|
journal
|
October 2013 |
|
Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure
|
journal
|
December 2014 |
|
Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface
|
journal
|
May 2022 |
|
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses
|
journal
|
November 2022 |
|
Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.
|
journal
|
December 1988 |
|
Immunosilencing a Highly Immunogenic Protein Trimerization Domain
|
journal
|
January 2015 |
|
Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials
|
journal
|
October 2019 |
|
Strategies for inducing effective neutralizing antibody responses against HIV-1
|
journal
|
November 2019 |
|
Influenza vaccine: progress in a vaccine that elicits a broad immune response
|
journal
|
August 2021 |
|
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
|
journal
|
August 2014 |
|
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo
|
journal
|
August 2017 |
|
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses
|
journal
|
May 2018 |
|
HIV Type 1 Env Precursor Cleavage State Affects Recognition by Both Neutralizing and Nonneutralizing gp41 Antibodies
|
journal
|
August 2011 |
|
Influenza vaccines: where we are, where we are going
|
journal
|
January 2022 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite
|
journal
|
June 2020 |
|
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
|
journal
|
July 2011 |
|
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
|
journal
|
July 2011 |
|
Highly Conserved Protective Epitopes on Influenza B Viruses
|
journal
|
August 2012 |
|
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
|
journal
|
October 2013 |
|
Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer
|
journal
|
October 2013 |
|
Dissociation of gp120 from HIV-1 virions induced by soluble CD4
|
journal
|
November 1990 |
|
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
|
journal
|
May 1996 |
|
Binding of HTLV-III/LAV to T4 + T Cells by a Complex of the 110K Viral Protein and the T4 Molecule
|
journal
|
January 1986 |
|
The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins
|
journal
|
June 1988 |
|
A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants
|
journal
|
November 1993 |
|
HIV-1 neutralizing antibodies induced by native-like envelope trimers
|
journal
|
June 2015 |
|
CAR T cell immunotherapy for human cancer
|
journal
|
March 2018 |
|
Binding Interactions between Soluble HIV Envelope Glycoproteins and Quaternary-Structure-Specific Monoclonal Antibodies PG9 and PG16
|
journal
|
July 2011 |
|
Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
|
journal
|
June 2013 |
|
A Broadly Neutralizing Human Monoclonal Antibody That Recognizes a Conserved, Novel Epitope on the Globular Head of the Influenza H1N1 Virus Hemagglutinin
|
journal
|
August 2011 |
|
Recombinant Soluble, Multimeric HA and NA Exhibit Distinctive Types of Protection against Pandemic Swine-Origin 2009 A(H1N1) Influenza Virus Infection in Ferrets
|
journal
|
October 2010 |
|
Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers
|
journal
|
November 2020 |
|
Robust Neutralizing Antibodies Elicited by HIV-1 JRFL Envelope Glycoprotein Trimers in Nonhuman Primates
|
journal
|
December 2013 |
|
Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity
|
journal
|
August 2015 |
|
Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes
|
journal
|
November 2018 |
|
Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers
|
journal
|
August 2015 |
|
New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency
|
journal
|
October 2015 |
|
Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits
|
journal
|
January 2020 |
|
Molecular Architecture of the Cleavage-Dependent Mannose Patch on a Soluble HIV-1 Envelope Glycoprotein Trimer
|
journal
|
November 2016 |
|
Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers
|
journal
|
December 2015 |
|
Identification of an HIV-1 Clade A Envelope That Exhibits Broad Antigenicity and Neutralization Sensitivity and Elicits Antibodies Targeting Three Distinct Epitopes
|
journal
|
March 2013 |
|
Flow Cytometry Reveals that H5N1 Vaccination Elicits Cross-Reactive Stem-Directed Antibodies from Multiple Ig Heavy-Chain Lineages
|
journal
|
February 2014 |
|
Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env
|
journal
|
March 2015 |
|
Engineering, Expression, Purification, and Characterization of Stable Clade A/B Recombinant Soluble Heterotrimeric gp140 Proteins
|
journal
|
January 2012 |
|
A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure
|
journal
|
January 2000 |
|
Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1
|
journal
|
September 2002 |
|
Enhancing the Proteolytic Maturation of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins
|
journal
|
March 2002 |
|
GP120: Biologic Aspects of Structural Features
|
journal
|
April 2001 |
|
scFv Antibody: Principles and Clinical Application
|
journal
|
January 2012 |
|
The expanding array of HIV broadly neutralizing antibodies
|
journal
|
October 2018 |
|
Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine
|
journal
|
October 2007 |
|
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
|
journal
|
December 2008 |
|
Enhanced Immunogenicity of Stabilized Trimeric Soluble Influenza Hemagglutinin
|
journal
|
September 2010 |
|
A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses
|
journal
|
January 2011 |
|
Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine
|
journal
|
March 2012 |
|
A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
|
journal
|
July 2012 |
|
HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers
|
journal
|
August 2017 |
|
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
|
journal
|
September 2013 |
|
Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C
|
journal
|
September 2016 |
|
Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques
|
journal
|
February 2018 |
|
Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates
|
journal
|
August 2020 |
|
A cross-neutralizing antibody between HIV-1 and influenza virus
|
journal
|
March 2021 |
|
Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens
|
journal
|
October 2021 |
|
Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity
|
journal
|
May 2011 |
|
HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies
|
journal
|
December 2015 |
|
Simian Adenoviruses As Vaccine Vectors
|
journal
|
September 2016 |
|
Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
|
journal
|
February 2018 |
|
Rapid Response Subunit Vaccine Design in the Absence of Structural Information
|
journal
|
November 2020 |
|
Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein Trimer
|
journal
|
October 2015 |
|
Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
|
journal
|
August 2021 |
|
Vaccinia Virus: From Crude Smallpox Vaccines to Elaborate Viral Vector Vaccine Design
|
journal
|
November 2021 |
|
A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
|
journal
|
April 2019 |
|
Specificity of CD8+ T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya
|
journal
|
May 2020 |
|
Self-Replicating RNA Viruses for Vaccine Development against Infectious Diseases and Cancer
|
journal
|
October 2021 |